Cadenza Bio welcomes Dr. Michael Panzara to its Board of Directors
– USA, OK – Cadenza Bio, Inc., a pioneering preclinical biotechnology company dedicated to developing innovative small-molecule drugs for the treatment of multiple sclerosis (MS) and other demyelinating and inflammatory diseases, announced the appointment of Dr.…